gene therapy - search results

Type-2 cannabinoid receptor (CB2R) is a G-protein-coupled receptor (GPCR) and an essential element of the endocannabinoid system (ECS) [1].

We hear from Rhea Horlock, Head of Corporate Social Responsibility at NHS Property Services (NHSPS), who discusses social prescribing & building for health.

Here, Doctor Peter J Houghton explains current therapies for childhood brain cancer what needs to change to ensure better outcomes for children diagnosed with astrocytoma in the future.

A team of researchers at the University of Freiburg and Delft University of Technology have joined forces to explore a new focused ultrasound technology to tap into the Neuronal Networks of Depression.

Cancers that are starved of oxygen, otherwise known as hypoxic cancers, are generally difficult to identify – but medical imaging has taken a new step with the MR-Linac scanner.

Jessica Riggleman, Owner of Raeco, LLC, examines the global regulatory landscape for psychedelic drugs, with a particular focus on Schedule I classification.

Jessica is the owner of Raeco, LLC, a Global Research Consulting Organization for pharmaceuticals and medical devices She has spent the last ten years in the clinical research industry and has worked closely with cross-functional teams to develop clinical evidence generation strategies for global regulatory submissions. Jessica has supported and published...

Professor Erika Dyck, Canada Research Chair in History of Health & Social Justice at the University of Saskatchewan, looks to psychedelic therapies outside the pharmaceutical industry to aid mental illness.

Here, Professor of Epidemiology & International Health Richard Hayes explores and details the PopART study and other trials of Universal Testing and Treatment, a promising strategy to reduce HIV spread.

In July 2022 the Women and Equalities Committee published a report focusing on menopause in the workplace, including recommendations to make menopause a protected characteristic under the Equality Act of 2010.

Abbas Kanani, Superintendent Pharmacist at Chemist Click Online Pharmacy, walks us through what we need to know about living with diabetes, starting with a comment on prediabetes.

Steve Haskew, the Group Director of Sustainability at Circular Computing – an organisation that sits at the centre of the circular economy – discusses the possibilities of remanufactured IT in the NHS.

Dr Lynne Green, Chief Clinical Officer at Kooth Digital Health, explores the symptoms, causes and treatments for major depressive disorder (MDD).

Dr Joana Torres, Gastroenterologist, Expert in Clinical IBD and UEG* Rising Star Awardee, highlights the most challenging aspects of living with inflammatory bowel disease and the unmet medical needs in IBD management.

Long Covid is affecting an estimated two million people in the UK; however, both the general population and the UK government have continued to overlook its impacts. This eBook sheds light on the life-changing condition.

In this interview, Abbas Kanani, MRPharmS, Superintendent Pharmacist at Chemist Click, tells us about amyloidosis, a group of rare diseases in which abnormal proteins deposit as amyloid in tissues and organs.

David Nutt FMedSci, Chair Drug Science and PAREA, Prof of Neuropsychopharmacology at Imperial College London, explains why Europe needs to catch up with psychedelic research.

Rick Rowan, CEO and founder of NuroKor Bioelectronics, tells us about how bioelectronic technology is changing the future of healthcare.

Dr Zisis Kozlakidis and Sandra Nanyonga discuss public health strategies, then and now, with a focus on the prevalence of STDs.

Hamilton Hall MD FRCSC, Executive Director, Canadian Spine Society/Back Care Canada, helps us to understand back pain, leg pain and how to manage the problem.